the aid library

Infant mortality and risk factors in Nigeria in 2013−2017: A population-level study

Shobiye, D.M.; et al (2022) CC

eClinicalMedicine 2022;00: 101622 Published online xxx https://doi.org10.1016j.eclinm.2022.101622

Hendra virus: Epidemiology dynamics in relation to climate change, diagnostic tests and control measures

Yuen K. Y.; Frase N. S.; et al (2021) C2

Hendra virus (HeV) continues to pose a serious public health concern as spillover events occur sporadically. Terminally ill horses can exhibit a range of clinical signs including frothy nasal discharge, ataxia or forebrain signs. Early signs, if detected, can include depression, inappetence, colic o ... more

The Therapeutic Potential of Ivermectin for COVID-19: a systematic review of mechanism and evidence

Kalafs.S.; et al (2021) CC

doi: https://doi.org/10.1101/2020.11.30.20236570 Pre-Print Article

Emerging and re-emerging human infectious diseases: A systematic review of the role of wild animals with a focus on public health impact

Cupertino, M. C.; Resende, M. B.; et al (2020) C2

Infectious diseases continue to impose unpredictable burdens on global health and economies, a subject that requires constant research and updates. In this sense, the objective of the present article was to review studies on the role of wild animals as reservoirs and/or dispersers of etiological age ... more

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc ... e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

A Global Research Agenda for Pediatric HIV

M. Penazzato; C. Irvine; M. Vicari; et al Journal of Acquired Immune Deficiency Syndromes (JAIDS); Ovid (2018) CC

Supplement Article www.jaids.com J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018

Clinical and Laboratory Diagnosis of Buruli Ulcer Disease: A Systematic Review

Sakyi; S.A.; Aboagye, S. Y.; Otchere, I. D. ; et al The Canadian Journal of Infectious Diseases & Medical Microbiology (2016) C1

Volume 2016 | Article ID 5310718 | https://doi.org/10.1155/2016/5310718. Buruli ulcer (BU) is a necrotizing cutaneous infection caused by Mycobacterium ulcerans. Early diagnosis is crucial to prevent morbid effects and misuse of drugs. We review developments in laboratory diagnosis of BU, discuss li ... more

Prioritization of Zoonotic Diseases in Kenya, 2015

Munyua P., A.Bitek, E.Osoro; et al (2016) CC

PlosOne https://doi.org/10.1371/journal.pone.0161576; Zoonotic diseases have varying public health burden and socio-economic impact across time and geographical settings making their prioritization for prevention and control important at the national level. We conducted systematic prioritization of ... more

FAMILIARIZÁNDONOS CON LA PARÁLISIS CEREBRAL: MATERIALES DE EXPOSICIÓN

International Centre for Evidence in Disability (ICED); London School of Hygiene and Tropical Medicine (LSHTM) ; CBM; et al (2014)

Trabajando con grupos de madres y padres – un recurso de capacitación para facilitadores, madres y padres, cuidadores, y personas con parálisis cerebral

GETTING TO KNOW CEREBRAL PALSY: DISPLAY MATERIALS

International Centre for Evidence in Disability (ICED); London School of Hygiene and Tropical Medicine (LSHTM) ; CBM; et al (2014)

Working with parent groups – a training resource for facilitators, parents, caregivers, and persons with cerebral palsy

FAMILIARIZÁNDONOS CON LA PARÁLISIS CEREBRAL

International Centre for Evidence in Disability (ICED); London School of Hygiene and Tropical Medicine (LSHTM) ; CBM; et al (2014)

Trabajando con grupos de madres y padres – un recurso de capacitación para facilitadores, madres y padres, cuidadores, y personas con parálisis cerebral

Cardiovascular risk in Mozambique: who should be treated for hypertension?

Damasceno, A; Padrão P; Silva-Matos, C; et al (2014) C1

This study aimed to estimate the proportion of Mozambicans eligible for pharmacological treatment for hypertension according to single risk factor and total cardiovascular risk approaches. It concluded that a total of 19.8% of 40–64-year-olds would be eligible for pharmacological treatment of hype ... more